Blog

NewsPrelivia

Prelivia Receives FDA Clearance

The U.S. Food and Drug Administration has provided 510 (k) Clearance for Prelivia, a neurostimulation device that promotes healthy blood circulation and maintains healthy tissue in people who are bedridden or chair bound. Annually, more than 2.5 million people in the United States suffer from pressure injuries, also known as bed sores, and up to 60,000 people die.

Prelivia

CABHI’s MC2 Program Accelerates Rehabtronics’ Path to Market

0

The Centre for Aging + Brain Health Innovation (CABHI) awarded access to its Mentorship, Capital and Continuation (MC2) program to Rehabtronics in January. The program helps companies unlock funding to accelerate business growth by providing access to leading investors, buyers, industry leaders and advisory from Silicon Valley.

Menu